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Abstract
Adipose tissue secreted cytokines (adipocytokines) have significant effects on the physiology and pathology of human
metabolism relevant to diabetes and cardiovascular disease. We determined the relationship of the pattern of these
circulating hormones with obesity-related phenotypes and whether such pattern is transmitted from parent to offspring. A
combined total of 403 individuals from 156 consenting Saudi families divided into initial (119 families with 123 adults and
131 children) and replication (37 families with 58 adults and 91 children) cohorts were randomly selected from the RIYADH
Cohort study. Anthropometrics were evaluated and metabolic measures such as fasting serum glucose, lipid profiles, insulin,
leptin, adiponectin, resistin, tumor necrosis factor alpha (TNFa), activated plasminogen activator inhibitor 1 (aPAI1), high
sensitivity C-reactive protein (hsCRP) and angiotensin II were also assessed. Parent-offspring regressions revealed that with
the exception of hsCRP, all hormones measured showed evidence for significant inheritance. Principal component (PC)
analysis of standardized hormone levels demonstrated surprising heritability of the three most common axes of
variation. PC1, which explained 21% of the variation, was most strongly loaded on levels of leptin, TNFa, insulin, and aPAI1,
and inversely with adiponectin. It was significantly associated with body mass index (BMI) and phenotypically stronger in
children, and showed a heritability of ,50%, after adjustment for age, gender and generational effects. We conclude that
adipocytokines are highly heritable and their pattern of co-variation significantly influences BMI as early as the pre-teen
years. Investigation at the genomic scale is required to determine the variants affecting the regulation of the hormones
studied.
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Introduction
The rising epidemic of overweight and obesity among developing
nations has been well established in several epidemiological studies
of different ethnic groups from all over the world [1–3]. However,
reductions in the over-all prevalence secondary to non-significant
trends in obesity patterns have been demonstrated in several
industrialized nations [4–7]. In the Kingdom of Saudi Arabia
(KSA), the most recent study conducted to determine the baseline
national prevalence of childhood obesity indicated an over-all
prevalence of 9.3%, considered intermediate between developing
and industrialized nation [8]. It is important to stress that the
indigenous Saudi population seems to have an increased genetic
predisposition to develop diabetes mellitus type 2 (DM T2), which is
further amplified by increased prevalence of obesity, high rates of
consanguinity, and the presence of other components of the
metabolic syndrome (MetS) [9]. The features of MetS include
insulin resistance, glucose intolerance, hypertension, dyslipidemia,
and central obesity, all of which are risk factors for coronary heart
disease (CHD) and DM T2. The rapid industrializations in KSA
and other developing nations have been accompanied by increased
prevalence of MetS even among younger populations [10].
Aside from thetraditional measurementsused to diagnoseobesity
and MetS, several key novel biomarkers, known as adipocytokines
or adipokines, have been associated with the regulation of body fat
and over-all human metabolism. Increased leptin, the satiety
hormone, and decreased adiponectin, the insulin sensitizing
adipocytokine, have been well established among those with
increased body fat [11–12]. Resistin, the adipocytokine initially
linked to obesity and insulin resistance in humans [13], has been
shown to be more related to inflammation and has been associated
with cardiovascular risk factors, including hypertension [14–16].
Increased levels of activated plasminogen activator inhibitor 1
(aPAI-1), tumor necrosis factor-alpha (TNFa), C-reactive protein
(CRP), as well as other conditions such as obesity and the MetS, are
now considered low-grade inflammatory states [17]. Lastly,
angiotensin II, which is the effector peptide of the renin-angiotensin
system (RAS), has regained the spotlight for its role in several
componentsofthe metabolicsyndrome,includinginsulinresistance,
hypertension and body weight regulation [18,19].
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alterations, as manifested by change of the biomarkers mentioned
above, transmit the same patterns of biomarkers to their offspring.
Several recent studies appear to support this hypothesis [20–22]. If
this is the case, then there is an urgent need to look for novel
biomarkers that may improve prediction of future risk for chronic
non-communicable diseases and allow understanding of the
underlying mechanisms that result in co-regulation of various
biomarkers. To the best of our knowledge, no study has as yet
analyzed a multitude of several metabolic phenotypes in terms of
heritability and association to key components of the MetS. The
purpose of this study was therefore to determine heritability
patterns among biomarkers of obesity, insulin resistance and other
markers of the MetS by measuring parent-offspring regressions in
subjects of Saudi Arab origin. This measure of heritability does not
necessarily imply a genetic mechanism, but does indicate
considerable familial structure to adipocytokine expression related
to MetS.
Materials and Methods
Ethical Statement
Written and informed consents were obtained from all
participants including parents, and assent from the children prior
to inclusion. Ethical approval was obtained from the research
ethics committee of the College of Medicine Research Center
(CMRC) in King Khalid University Hospital, Riyadh, KSA.
Subjects
This cross-sectional study was carried out at the Biomarkers
Research Program, King Saud University (KSU), Riyadh, KSA. A
total of 254 subjects or 119 families (123 adults and 131 children)
were randomly selected from the RIYADH COHORT, a capital-
wide study supported by the Ministry of Health and King Saud
University for the screening of novel biomarkers of more than
16,000 Saudi subjects (aged 1–80 years) recruited from different
primary care centers all over Riyadh, KSA. Families were
randomly selected from the database using the Microsoft Excel
function. Subjects, who were on medications for diabetes and
hypertension without complications (e.g. diabetic complications,
coronary artery disease, liver or kidney failure), were included to
avoid selection bias. Patients were asked to complete general
questionnaires, which included medical history.
Anthropometrics
Anthropometrics was carried out by a designated nurse and
physician, as part of an on-going research program ascertaining:
height (to the nearest 0.5 cm), weight (to the nearest 0.1 kg), waist
and hip circumferences (measured using a standardized measuring
tape in cm), in addition to systolic and diastolic blood pressure
measurements. BMI was calculated as kg/m
2. Obesity for adults
was defined as having a BMI of $30 kg/m
2, while overweight was
defined as a BMI of .25 but ,30 kg/m
2. Classification of obesity
for children was based in the international age and gender-specific
criteria proposed by Cole and colleagues [23].
Biochemical Measurements
Morning fasting blood samples were taken previously from the
on-going RIYADH COHORT and were kept in the biobank of
the Biomarkers Research Program (BRP) at KSU. Serum glucose
and lipid profile were determined using routine laboratory
methods. Serum insulin, leptin, adiponectin, resistin, TNFa and
aPAI-1 were quantified using multiplex assay kits that utilize
fluorescent microbead technology, allowing simultaneous quanti-
fication of several target proteins within a single serum sample of
50–100 mL [24]. These included pre-mixed and fully customized
panels that utilize the LuminexH xMAPH Technology platform
(Luminexcorp, TX, USA). For parameters measured using the
multiplex assay, the intra-assay variation was 1.4-7.9% and inter-
assay variation of ,21%. Minimum detectable concentrations
(MDC) were as follows: insulin, 50.9 pg/ml; leptin, 85.4 pg/ml;
adiponectin, 145.4 pg/ml; resistin, 6.7 pg/ml; TNFa, 0.14 pg/ml,
and PAI-1, 1.3 pg/ml. hsCRP was determined using enzyme-
linked immunosorbent assays (ELISA) (Immunodiagnoztik AG,
Bensheim, Germany) with an intra-assay variability of 5.5–6.0%
and inter-assay variation of 11.6–13.8%. Angiotensin II (ANG II)
was quantified using fluorescent-based non-radioactive immuno-
assay (MDC 13pg/ml; linear range 13–240 pg/ml) (Phoenix
Pharmaceuticals, CA, USA). All fasting samples fell within the
detection range.
Replication Cohort
An additional cohort of 149 Saudi individuals or 37 families (58
adults, 91 children) was randomly selected from the master
database of RIYADH COHORT for generation of a replication
dataset.
Statistical analyses
Descriptive statistics reported in Table 1 were generated using
SPSS version 11.5 (Chicago, IL). Frequencies were presented as
percentage, while continuous variables that assumed normality
was shown as mean 6 standard deviation. Medians (inter-quartile
range) were shown for non-normal continuous variables. Inde-
pendent Student t-test was used to compare gender differences for
normal parameters and chi-square for frequencies. For non-
normally distributed parameters, the Mann-Whitney U-test was
utilized for comparisons. All subsequent analyses were performed
using SAS/JMP version 4 (Cary, North Carolina). Pearson
correlation and regression analyses were performed on standard-
ized residuals from linear models of systolic and diastolic blood
pressure, the anthropomorphic measures, or log-transformed
measures of glucose, triglycerides, cholesterols, insulin, leptin,
adiponectin, resistin, TNFa, ANG II, aPAI1 and hsCRP that
included covariates representing cohort, gender, generation, and
age within generation. Principal component analysis was per-
formed on the correlations among the standardized residuals for
the seven adipocytokines.
Results
The general characteristics of both parents and children are
presented in Table 1. There was a high prevalence of obesity in
both cohorts, and a high prevalence of T2DM and hypertension
among parents. The concentrations of eight hormones (insulin,
leptin, adiponectin, resistin, TNFa, ANG II, aPAI1 and hsCRP),
as well as the various other metabolic measurements, were
determined in the initial cohort of 254 individuals, consisting of
119 parent-offspring pairs as well as 12 additional siblings and 2
parents. After adjustment for gender and generational effects, BMI
was significantly influenced by five hormones (leptin, insulin,
adiponectin, aPAI1 and hsCRP). Furthermore, the first principal
component of the hormones also influenced BMI and showed
evidence for significant heritability. Consequently, we sought to
replicate these results with our second cohort consisting of 149
individuals from 37 families (21 with both parents), with an
average of 2.5 children per family. Because the sub-cohort analysis
provided similar results, a combined analysis of all 403 individuals
from 156 families was undertaken; any discrepancies between
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provide the analyses for each cohort separately.
Heritability of Metabolic Factors
Parent-offspring regressions, which provide an estimate of
heritability, were estimated for serum concentrations of eight
hormones, five metabolites, and anthropometric parameters, as
shown in Table 2 (initial and replicate cohort parent-offspring
regressions are shown in Table S1 and S2, respectively). Each of
the variables measured, with the exception of hsCRP, showed
evidence for highly significant inheritance, as did all three
cholesterol measures (total, HDL-, and LDL-cholesterol). The
leptin, insulin, and adiponectin parent-offspring regressions were
only significant in the replication cohort (Figure 1), suggesting that
measuring both parents as well as multiple children increased the
power of this analysis; only aPAI1 showed reduced significance in
the replication cohort. BMI was also significant in both cohorts,
although the regression explained less than 10 percent of the
phenotypic variance. Heritability was estimated as twice the slope
of the regression in the initial cohort, where only one parent was
available, and as the slope of the regression in the replication
cohort: with considerable error it ranges between ,25% (leptin)
and ,63% (TNFa).
In order to assess whether adipocytokines are co-regulated in a
heritable manner, principal component (PC) analysis was performed
on the standardized hormone levels. Surprising heritability of the
three most common axes of variation, which jointly explained 51%
of the variation, was observed. PC1 (21%) was most strongly loaded
on levels of leptin, TNFa,i n s u l i n ,a n da P A I 1 ,a n di n v e r s e l yw i t h
adiponectin, and showed a heritability of ,50%, which is at least as
large as that of the individual contributing hormones. Table 3
indicates that these loadings are consistent in both cohorts and in the
combined analysis, with the exception of Angiotensin II, which does
not co-vary consistently with the metabolism-regulating hormones.
PC2 (15%) is less significantly transmitted from parent to offspring,
largely because 20 individuals had elevated levels of resistin, TNFa,
orhsCRP that influence the loadingsfor this component (Figure 1B).
PC3 (15%) was as heritable as PC1, and loaded adiponectin, aPAI1
and TNFa against leptin, insulin, and CRP.
Correlation of Metabolic Factors with Adipocytokines
We next asked whether any of the hormones measured correlated
with metabolic phenotypes by fitting linear models with cohort,
generation, gender, and age within generation as covariates. The
significance of the effect of each hormone or principal component, as
well as the percent variance explained by each model, is shown in
Table 4. These values should be contrasted with the null model (top
line) that only includes effects of age, gender, and generation.
Table 1. General Characteristics of Parents and Children.
Parameter Parents Children
N 123 131
Obesity (%) 47.9 29.7
DM T2 (%) 30.6 0
Hypertension (%) 14.0 0
Age (years) 45.9610.1 9.3762.6
Anthropometrics
BMI (kg/m
2) 30.065.6 20.065.5
Waist circumference (cm) 95.4613.3 62.865.7
Hips circumference (cm) 104.966 72.2615.0
Systolic BP (mmHg) 121.2612.6 99.8615.0
Diastolic BP (mmHg) 79.669.1 66.068.0
Metabolites
Glucose (mmol/L) 7.163.7 4.961.0
Triglycerides (mmol/L)# 1.5 (1.03–2.5) 0.88 (0.7–1.2)
Total Cholesterol (mmol/L) 5.261.1 4.460.9
LDL-Cholesterol (mmol/L) 3.460.9 2.860.7
HDL-Cholesterol (mmol/L) 0.8660.23 1.160.29
Hormones
Insulin (IU/ml)# 8.3 (5.6–13.0) 5.9 (3.6–9.1)
Leptin (ng/ml)# 11.9 (5.3–18.6) 4.5 (1.7–13.7)
Adiponectin (mg/ml)# 8.4 (6.2–14.7) 19.6 (13.6–28.0)
Resistin (ng/ml)# 18.6 (13.8–25.3) 16.2 (12.3–23.2)
TNFa (pg/ml)# 2.9 (2.1–4.3) 3.9 (2.6–5.3)
aPaI-1 (pg/ml)# 7.3 (1.7–18.8) 11.6 (4.4–21.4)
ANG II (ng/ml)# 0.54 (0.43–0.75) 0.57 (0.44–0.73)
hsCRP (mg/ml)# 3.2 (1.1–7.0) 0.9 (0.28–3.4)
Note: Data is presented as % for frequency; mean 6 standard deviation for
normally distributed data; # denotes non-Gaussian distribution and thus
presented as median (inter-quartile range).
doi:10.1371/journal.pone.0018182.t001
Table 2. Unadjusted Parent-Offspring Regressions for Raw
Trait Measures.
Trait Slope R
2 N pairs P-Value
BMI (kg/m
2) 0.30 0.06 207 0.0002
Glucose (mmol/L) 0.06 0.00 196 0.21
Triglycerides (mmol/L) 0.06 0.02 196 0.04
Total Cholesterol (mmol/L) 0.32 0.17 195 2610
29
LDL-Cholesterol (mmol/L) 0.34 0.21 194 1610
211
HDL-Cholesterol (mmol/L) 0.43 0.15 196 2610
28
Leptin (ng/ml) 0.25 0.09 175 5610
25
Insulin (IU/ml) 0.29 0.04 176 0.007
Adiponectin (mg/ml) 0.31 0.06 200 0.004
Resistin (ng/ml) 0.40 0.21 196 6610
212
TNFa (pg/ml) 0.58 0.26 169 7610
213
aPaI-1 (pg/ml) 0.41 0.17 180 4610
29
ANG II (ng/ml) 0.45 0.10 172 1610
25
hsCRP (mg/ml) 0.05 0.00 195 0.45
Principal Component 1 0.43 0.17 200 1610
29
Principal Component 2 0.16 0.03 200 0.010
Principal Component 3 0.45 0.17 200 6610
210
Adj. Height (cm) 0.24 0.03 199 0.006
Adj. Weight (kg) 0.22 0.04 200 0.003
Adj. Hip circumference (cm) 0.46 0.21 192 1610
211
Adj. Waist circumference (cm) 0.44 0.21 195 2610
211
Waist-to-hip ratio 0.12 0.01 194 0.18
Systolic blood pressure (mmHg) 0.10 0.01 173 0.16
Diastolic blood pressure
(mmHg)
20.06 0.00 173 0.44
Note: Adj = adjusted; Significant at P,0.05.
doi:10.1371/journal.pone.0018182.t002
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and both adiponectin and insulin correlate modestly with total
triglycerides, but no other tests were significant after adjustment for
multiplecomparisons. BMI associated highly significantly with leptin,
aPAI1, and CRP (and to a lesser extent adiponectin and insulin), as
well as with PC1, which (like leptin) explains as much as 10% of the
variance of BMI on top of the age, gender and generational effects.
These results were quite consistent between the two cohorts.
Most of these correlations were considerably stronger in the
children than adults, as noted in Figure 2. PC1 explains 22% of BMI
in children (p,3610
215), and 15% in adults (p,2610
27), and
similarly, leptin (31%, p,5610
220 in children; 17%, p,5610
28
adults) was strongly associated with BMI. The aPAI1, insulin, and
adiponectin effects were only significant in the children, as was the
angiotensin influence on HDL cholesterol (8% explained, p,0.0005),
though all these effects trended in the same direction in adults.
Figure 1. Parent-Offspring Regressions. Each plot shows the regression for the indicated adipocytokine measure of the child against the parent
or mid-parent (where both parents were measured). Each measure is normalized and adjusted for generation, gender, cohort, and age within
generation. Gray circles and dashed line indicate the initial cohort (generally single parent-child pairs) and the black circles and solid line indicate the
replication cohort (generally larger families). (A) Leptin. (B) Adiponectin. (C) Insulin. (D) Principal Component 1. (E) PC2. Note that removal of a dozen
outliers with high levels of resistin results in a much stronger regression. (F) PC3. Regression coefficients and significance are indicated in
Supplementary Tables, and in Table 2 for the combined dataset. R-squared and p-values correspond to the combined dataset as documented in
Table 2.
doi:10.1371/journal.pone.0018182.g001
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Given the strong evidence for parent-offspring correlation,
as well as association of adipocytokines with BMI, we next
asked whether specific families in the replication cohort
showed aberrant profiles for specific hormones, where each
member of the family lies in the upper or lower quartile for
two or more measures. Two examples involving resistin are
illustrated in Figure 3. Families 157 and 160 had relatively
high resistin but low TNFa levels (and 157 also had low
aPAI1); Families 129 and 148 had low resistin but high insulin;
and families 124 and 128 had low resistin coupled with high
leptin levels. Correspondingly, 4 of 5 members of family 128
w e r ei nt h eu p p e rq u i n t i l ef o rB M Ia n dl o w e rq u i n t i l ef o r
HDL-C (the fifth child was just 10 years old at time of
sampling), and for family 124 HDL was uniformly low while
the parents and older child were obese. By contrast, members
of families 157 and 160 all had BMI measures in the lower half
for their generation.
Discussion
Recent epidemiologic evidence using the same ethnic group in
this study highlight a dysmetabolic pattern that was observed to be
common in both adults [25] and children [10], suggesting that not
only childhood weight gain but also abnormal biochemical profiles
associated with the components of the metabolic syndrome, are
highly heritable [26,27]. While results from the present study
involving a sample of 403 Saudi subjects strengthen these
hypotheses, the major novel finding is that various adipocytokines
and inflammatory markers also show highly significant parent-
offspring regressions which, consequently, also correlate significant-
ly with BMI. Several studies involving leptin [26,28], adiponectin
[29,30] and resistin [31], have individually shown pleiotropic effects
to obesity-related phenotypes with significant heritability estimates.
To the best of our knowledge however, this is the first study to
demonstrate inherited metabolic patterns involving a multitude of
adipocytokines and inflammatory markers in an at risk population.
In the present study, the hormone-phenotype correlations are
strongerinchildren between the ages of5 and 18asopposedtotheir
parents.SinceBMIandotherobesity-relatedphenotypes arelargely
dictated by a stronger genetic influence from early years to young
adulthood [32,33], our results suggest that the expression of obesity-
related hormones used in this study follow the same genetic
influence in this period, with environmental factors probably
playing an increasingly important role later in life. In fact, the
somewhat weaker correlations with BMI among parent subjects
(adults) are consistent with the weakening of any mechanism of
genetic regulation under the influence of cumulative environmental
exposures, as individuals’ age [20,34]. Furthermore, aside from the
dietary and behavioral factors inducing a pro-obesity adipocytokine
profile in adults, it is possible that this condition is established early
in life in the at risk population, and modified as people age. While
large-scale studies of obesity involving parent-offspring subjects
overwhelmingly indicate an increased risk to childhood obesity
among those having overweight parents [35–37], None of these
studies actually showed whether genetic predisposition to obesity by
itself will translate to an equally heritable obesity-related abnormal
Table 3. Principal Component (PC) Loadings.
PC1 PC2 PC3
Init Rep Total Init Rep Total Init Rep Total
Adiponectin 20.27 20.46 20.29 0.11 0.26 0.31 0.56 0.41 0.59
ANG II 20.42 0.45 0.20 0.46 20.17 20.28 0.01 0.26 0.20
aPAI1 0.56 0.20 0.39 20.05 0.44 0.61 0.34 0.51 0.06
hsCRP 0.04 0.11 0.28 0.46 0.39 20.54 20.43 20.64 0.22
Insulin 0.31 0.21 0.33 0.21 0.31 20.18 20.32 20.15 20.09
Leptin 0.43 0.46 0.51 0.14 0.25 20.02 20.21 20.25 20.20
Resistin 20.02 20.24 0.16 0.63 0.62 20.15 0.18 20.01 0.70
TNF-a 0.40 0.47 0.50 0.30 0.09 0.31 0.45 0.36 0.13
Note: Data are presented as eigenvalues; Init = Initial Cohort; Rep =
Replication Cohort.
doi:10.1371/journal.pone.0018182.t003
Table 4. Adipocytokine Correlations with Metabolic Measures.
BMI Total Cholesterol HDL-C LDL-C Triglycerides
R
2 Sig R
2 Sig R
2 Sig R
2 Sig R
2 Sig
Null 0.51 0.15 0.10 0.15 0.17
PC1 0.61 5610
221 0.15 NS 0.11 NS 0.15 NS 0.17 NS
PC2 0.51 0.05 0.15 NS 0.11 NS 0.16 NS 0.17 NS
PC3 0.51 NS 0.15 NS 0.12 0.07 0.15 NS 0.18 0.02
Leptin 0.65 1610
223 0.18 NS 0.11 NS 0.17 NS 0.17 NS
Insulin 0.54 0.0031 0.17 NS 0.13 0.04 0.17 NS 0.19 0.002
TNFa 0.53 NS 0.18 NS 0.11 NS 0.17 NS 0.16 NS
Adiponectin 0.52 0.0003 0.16 NS 0.12 0.06 0.15 NS 0.18 0.006
aPAI1 0.54 2610
25 0.15 NS 0.09 NS 0.15 NS 0.16 NS
Resistin 0.51 NS 0.15 NS 0.11 NS 0.15 NS 0.17 NS
hsCRP 0.54 6610
28 0.15 NS 0.13 0.02 0.16 NS 0.17 NS
ANG II 0.52 NS 0.15 NS 0.15 5610
25 0.15 NS 0.19 NS
Note: Table shows percent variance explained (R
2) by the full model including Cohort, Generation, Gender, and Age(Gender), as well as the indicated adipocytokine (or
principal component) with BMI or metabolite levels, as well as the significance of the adipocytokine/PC term. The first row labeled Null is the model without an
adipocytokine/PC, and shows the variance explained jointly by Cohort, Generation, Gender and Age (Gender) for comparison.
doi:10.1371/journal.pone.0018182.t004
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the first to reveal that the pattern of covariance in adipocytokine
abundance, as clustered in the first major principal component, was
not only highly predictive of body mass index, but also significantly
transmitted from parent to offspring.
The strong correlation of the hormones studied with BMI and
HDL-cholesterol in children between the ages of 5 and 18 is
noteworthy from the perspective of the global epidemic of
childhood obesity. This was observed not only for individual
hormones, but also for the first principal component, suggesting
that whatever mechanism accounts for the co-regulation is
operating early in life. Particularly noteworthy is the significantly
stronger association of ANG II to HDL-cholesterol in children,
mechanisms which might involve translocation of scavenger
receptor type-BI (SR-BI) in the adipose tissue [38], or angioten-
sin-converting enzyme (ACE) polymorphisms that were recently
linked to components of the metabolic syndrome including HDL-
cholesterol [39], both of which require further investigation.
Figure 2. Adipocytokine – Phenotype Correlations. Each plot shows the regression of the indicated phenotype (A–C: Body Mass Index; D:
serum HDL-Cholesterol) against the standardized measure of adipocytokine (B: Leptin; C: Adiponectin; D: Angiotensin II) or PC1 (A). Red points are the
parents, blue points the children. Note that in each case the correlation is stronger in the children, and that although the regressions for PC1 and
leptin explain similar proportions of the variance, as indicated in Table 3, the PC1 values cover a more even spread of values and are more consistent
across the generations. R-squared and p-values correspond to the full model as documented in Table 4.
doi:10.1371/journal.pone.0018182.g002
Figure 3. Clustering of Phenotypes in Families. Several families in the replication cohort were observed where each of the parents and their
children were in the upper or lower quartile for age-adjusted BMI, as well as for two or more adipocytokine measures. Shading of each circle
corresponds to age-adjusted BMI (low BMI, light; high BMI dark), and the filled circles represent members of two families in each plot. (A) All members
of families 124 and 128 were obese and had high leptin coupled with low resistin concentrations. (B) All members of families 157 and 160 had low
TNFa but high resistin concentrations and were in the lowest third of age-adjusted BMI.
doi:10.1371/journal.pone.0018182.g003
Heritability of Adipocytokines
PLoS ONE | www.plosone.org 6 April 2011 | Volume 6 | Issue 4 | e18182Particularly in human studies, caution is required in interpreting
heritability estimates from parent-offspring regression as strong
evidence for a genetic component, since family members share
cultural and social environments. Genotype-based studies would
be required to establish that genetic variation influences
adipocytokine levels. Genome-wide association studies (GWAS)
have uncovered several loci that affect BMI [40,41]. Our results
establish the minimal requirements for GWAS of adipocytokine
levels as potential mediators of increased body mass and
subsequent susceptibility to chronic non-communicable diseases
including DM T2. This strategy would be particularly revealing if
it uncovered variants affecting the covariance of leptin, TNFa,
insulin, aPAI1 and adiponectin, in particular, that generates PC1.
Indeed, while adipocytokine effects have been well studied in
adults, these results call for more extensive studies of their impact
on metabolic physiology that encompasses even pre-teenage
children.
In conclusion, this study highlights the existence not just of
individuals, but of families that show somewhat unusual
combinations of adipocytokines that are likely to contribute to
elevated risk of chronic diseases. These families might have had
specific environmental exposures that lead to the aberrant
patterns, but the possibility that segregation of genetic polymor-
phisms is responsible should be pursued. Further studies at the
genomic scale are required, examining individuals with extreme
phenotypes, as the power of whole genome sequencing promises to
identify not only mutations of large effect, but also target genes
that can be utilized for the development of customized
pharmacologic interventions.
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